9 – 10 May 2026
Business Design Centre, London
Business Design Centre, London
Epigenetic Reprogramming and the Future of Longevity Medicine
Dr. Khan is a Canadian board-certified physician, founder and CEO of Eterna Health, and a globally recognized pioneer in regenerative medicine, redefining the future of health, vitality, and recovery through groundbreaking work with stem cells and peptides.
A graduate of the University of Ottawa’s Faculty of Medicine, he has built a career focused on therapies that help the body heal at its core while transforming how we think about longevity, well-being, and personal health. His innovative treatments have earned international recognition and the trust of healthcare professionals, elite athletes, and patients worldwide.
After beginning his journey in sports medicine, Dr. Khan shifted toward regenerative and cell-based therapies to offer alternatives to conventional surgery and medications, guided by the belief that the body has an innate ability to repair itself when given the right tools. Today, he stands at the forefront of modern medicine with a visionary approach that is changing how healthcare is delivered and experienced.
Globally recognized for his expertise in stem-cell technology, Dr. Khan helps patients avoid surgery, alleviate chronic pain, reverse illness, and slow aging—even when other options have failed. His work continues to bridge cutting-edge science with practical clinical application, positioning regenerative medicine as a powerful driver of the future of longevity care.
Today, in his talk, “Epigenetic Reprogramming and the Future of Longevity Medicine,” Dr. Khan will explore how restoring youthful cellular patterns may unlock new pathways for rejuvenation and prevention, bringing us closer to a future where extending healthspan becomes a clinical reality.